Dabrafenib is a type of targeted cancer therapy. It is a prescription medication used to treat a certain type of advanced skin cancer called melanoma. It belongs to a group of medicines called kinase inhibitors. Dabrafenib works by blocking certain proteins that help cancer cells grow and divide, thus slowing the growth and spread of cancer cells. This medication is usually taken in combination with another medication called trametinib.
Dabrafenib, sold under the brand name Tafinlar among others, is a medication used to treat specific cancers caused by a genetic mutation [1, 2]. Here's a closer look at Dabrafenib:
Function:
- Dabrafenib belongs to a class of drugs called kinase inhibitors [2].
- It targets a specific enzyme called BRAF which plays a role in cell growth regulation [1, 2].
- By inhibiting BRAF, Dabrafenib helps slow down the growth and spread of cancer cells with the BRAF mutation [2].
Applications:
- Dabrafenib is used alone or in combination with another medication called Trametinib to treat various cancers with the BRAF V600E mutation [2, 3, 6]. These cancers include:
- Certain types of melanoma (skin cancer) [2, 3].
- Non-small cell lung cancer (NSCLC) [2, 3].
- Anaplastic thyroid cancer [3].
- Other solid tumors in adults and children (depending on the specific type) [3].
Important Points:
- Dabrafenib is only effective for cancers with the BRAF V600E mutation. A confirmatory test is required before starting treatment [4, 5].
- It comes in capsule form and is taken orally [2].
- Dabrafenib can cause side effects, some of the most common being fatigue, nausea, vomiting, skin problems, and joint pain [2].
- Due to the medication's blood-thinning properties, there's an increased risk of bleeding. It's crucial to discuss this with your doctor [2].
Remember: I cannot provide medical advice. If you have questions about Dabrafenib or its suitability for you, consult a healthcare professional. They can guide you based on your specific condition and medical history.